Institutional Review Board FAQ
BGSU's Institutional Review Board (IRB) reviews all research projects involving human subjects.
If your project/research meets the federal definitions of “research” with a “human subject” your research must be reviewed by the IRB (see below).
The IRB strongly suggests that you confirm if your project needs review with the Office of Research Compliance. An informal determination can be made by calling the office (419-372-7716) and a formal determination can be made by completing and submitting the Review Determination Form.
The Review Determination Form can be found in IRBNet. The completed form must be submitted in IRBNet to the BGSU IRB. Instructions for using IRBNet can be found on the IRB home page and in IRBNet under the Forms and Templates section.
“Research means a systematic investigation, including research development, testing and evaluation, designed to develop or contribute to generalizable knowledge. Activities which meet this definition constitute research for purposes of this policy, whether or not they are conducted or supported under a program which is considered research for other purposes. For example, some demonstration and service programs may include research activities.” (45 CFR 46.102.d)
“Human subject means a living individual about whom an investigator (whether professional or student) conducting research obtains (1) Data through intervention or interaction with the individual, or (2) Identifiable private information.” (45 CFR 46.102.f)
First, you must complete Human Subjects Training. The University has a requirement that the Principal Investigator (and the project advisor, if the Principal Investigator is a student) complete the training in order to get a project reviewed. Training can be accomplished either by attending a "live" training session or completing web-based training. Information regarding those alternatives can be found here.
Following successful completion of the training, complete the HSRB application, which can be found in IRBNet.org.
Next, you should develop informed consent documents. For help in putting the document together, the IRB created an Informed Consent Checklist that identifies the necessary pieces of information to be included in the consent document, and a suggested outline for the consent document. These documents can be found in IRBNet.org.
Finally, submit the completed IRB application, recruiting materials, consent documents and associated data collection instruments or protocol (e.g., questionnaires, focus group questions, interview questions, etc.) as appropriate, in IRBNet.org. Directions on how to submit materials using IRBNet are found on the IRB home page.
Yes. The IRB periodically revises the protocol application form in order to clarify what information researchers must provide about the proposed study. Using the most recent version of the form will ensure that your submission is processed and reviewed in a timely manner.
Beginning August 26, 2013, the IRB will utilize an exempt review procedure. This is in addition to the expedited and full board review procedure. In order to facilitate the routing of submissions, the first page of the protocol application form has been updated.
- For projects receiving expedited review during the academic year, expect to receive results of the initial review in 10 to 14 business days following submission. Note that the turnaround time may vary depending upon the number of submissions in IRBNet.
- Projects requiring full board review are reviewed at the Board's monthly meetings, generally held on the 1st Wednesday of each month. The Office of Research Compliance strives to get review results back to Principal Investigators within 7 - 10 business days of the meeting at which the project is reviewed, depending upon the number of projects on the meeting agenda. See the IRB Review Schedule for submission deadlines.
- Important - Regardless of the type of review, if you have not heard back from the Office of Research Compliance within 15 - 20 business days of submission, please check the status of your submission in the IRBNet.org system or call the office at 419-372-7716.
- For projects receiving expedited review you should submit your IRB application at least five weeks in advance of your planned start.
- For projects receiving full Board review you should submit your IRB application for review at the IRB meeting two months in advance of your planned start. See the IRB Review Schedule for monthly meeting dates and associated submission deadlines.
- In most cases, following these guidelines should provide sufficient time to allow your project to receive final approval in advance of its planned start date.
- Research involving prisoners (e.g., individuals in prisons, halfway houses, certain parolees - e.g., those residing in a treatment facility as a condition of parole)
- Some types of research with children (<18 years old) - for example if a waiver of parental consent is requested
- Research with other vulnerable populations (e.g. institutionalized individuals, pregnant women)
- Research presenting more than minimal risk
The federal regulations governing research with human subjects require review of an active research project no less frequently than once a year. Therefore, the IRB can only approve a project for a maximum of a 12 month period. After the initial approval period, a project can be continued for an additional period at the request of the investigator. Any modifications from the original project must be approved, however (see question 8 for more information on this).
Eleven months (or less depending upon specific project characteristics) after initial review, an investigator (and advisor, if the researcher is a student) should receive a Continuing Review Update form via email. This form asks the investigator to provide information regarding the project, such as the status of the project (completed or continuing), the number of subjects involved, if any adverse events occurred. This form should be returned, along with copies of current consent documents, to IRBNet.org. If the project has been completed, the file will be marked as such and archived. If the project is continuing, it will be reviewed by the IRB. The investigator will be notified of the results of the review, including any changes to consent documents that may be required as the result of guidance provided by the federal government. When approval is granted, it will usually be for a 12-month period, but could be shorter depending upon the specific characteristics of the project. Continuing Review reminders will be sent each year until the project is completed.
Often investigators are students who have finished the project and left BGSU. In that case, it is the advisor's responsibility to complete the form and return it to the Office of Research Compliance along with current copies of consent documents. It is also the advisor's responsibility to know the number of subjects used and whether or not there were any adverse events, withdrawals, etc.
The IRB and Office of Research Compliance appreciate the efforts taken by many of you to complete updates for projects in a timely manner. If you have any questions about the continuing review process contact Dr. Hillary Snyder or any member of the IRB.
Complete a Request for Modification/Addendum form and return it and relevant supporting materials (e.g., new/revised recruiting documents, consent forms, data collection instruments, etc.) to IRBNet.org. The form is available through www.IRBNet.org. The response commitment for review of modification requests is the same as for new applications (see question 4 above).
The IRB has the authority to require submission of a completed IRB application by anyone conducting research in which BGSU faculty, staff and/or students are involved as participants. Please contact the Office of Research Compliance for additional information. If IRB review and approval is required, see IRB Policy/Procedure statement - Initial Review- External Researcher Applications on the IRB Procedure web page for instructions.
Effective February 1, 2001 BGSU instituted a policy which requires the Principal Investigator (PI) and the PI's advisor (if the PI is a student) to have obtained human subjects training in order for a research project to be reviewed by the HSRB. See the IRB Training Schedule for session times and dates. Note: web-based training is now available. See the IRB Training Schedule for details.
When you leave BGSU, IRB approval of your project is no longer applicable. If you plan to continue the project at your new institution you should seek IRB review through that organization.
Guidance from OHRP states even projects in the analysis stage should receive continuing review. Therefore, you should fill out the form indicating the project is in analysis and return it to IRBNet.org for continuing review processing. For graduate students working on their thesis or dissertation work, it also makes sense to do so just in case their committee asks them to collect more data or recontact participants.
Yes, you should be aware of the Health Insurance Portability and Accountability Act (HIPAA) and its impact on research with human participants. This act was passed in 1996 as part of an effort by the Federal government to standardize and provide safeguards for the electronic transmission of health information of U.S. citizens. Two standards or "rules" have been published - The Transaction Rule and the Privacy Rule. The Privacy Rule has specific requirements related to the use and/or disclosure of protected health information for research purposes .
This PowerPoint presentation provides basic information regarding the "Privacy Rule" and research. Contact the Office of Research Compliance for assistance.
Click this link for guidance from the Department of Health and Human Services' Office for Civil Rights on research aspects of the Privacy Rule.
The Department of Health and Human Services has developed a web site to provide the research community with information about the HIPAA Privacy Rule and how it might affect research. Click this link to go to that web site.
If the intended use of the data collected are solely for reporting back to the funding agency as a basis for evaluating the project, then the associated data collection activities typically do not require IRB review and approval (keep in mind that there are some federal agencies, such as the Centers for Disease Control (CDC), that may require evaluative data collection activities to receive IRB review and approval).
However, the Board recognizes that there may be situations where you want to use the evaluation data for research purposes or to collect additional data from your project participants strictly for research purposes. In these situations IRB review and approval of the research-related aspects are required. In either case (use of evaluation data for research or collection of additional data strictly for research) your consent document(s) should clearly differentiate the evaluation components (for which participation is generally mandatory) from the research related components (for which participation in or use of collected evaluation data is voluntary).
The Office for Human Research Protections has issued guidance that recommends Institutional Review Boards put approval and expiration dates on all approved consent documents and stipulate that copies of the dated documents be used in obtaining consent. The thought here is that this will help ensure only the current, IRB approved consent documents are presented to prospective subjects. The IRB has decided to implement this recommendation in order to help researchers in their efforts to use the approved versions of consent documents. Click this link to go to the IRB's policy/procedure statement in this regard.
The federal regulations for the protection of human research subjects do not require documentation that an individual does not want to participate in a project. In general, the IRB’s perspective is that the researcher does not need to know the identities of individuals who decline participation in his/her project.
The Board does, however, recognize that there are situations in which documenting either the willingness or unwillingness of a prospective subject to participate in a project could be appropriate. For example, a researcher who is introducing a study on a sensitive topic to a group of individuals may want to provide both a negative (e.g., “I do not want to participate”) and a positive (e.g., “I do want to participate”) option on the consent form and have everyone complete and return the consent form. In this manner the privacy of individuals who opt to participate (or for that matter, to not participate) in the project is protected because everyone is completing and returning a consent form (some indicating willingness to participate, others declining participation).
The IRB would expect that projects where both choices (participation and non-participation) are formally provided on a consent document would be relatively rare and the need for such an approach would require justification to the Board. That justification should also include an indication of the planned disposition of consent forms obtained from individuals who decline participation and, if retention of them is desired, an associated justification of that need.
If you believe the use of this type of consent document would be needed for your project, contact the Office of Research Compliance to discuss the project.
The federal Office for Human Research Protections (OHRP) has developed an International Compilation of Human Subject Research Protections (Note - this compilation has been updated for 2008). This compilation lists the laws, regulations, and guidelines of 84 countries (over 900 laws regulations, and guidelines). The compilation can be accessed on the OHRP website at: http://www.hhs.gov/ohrp/international/intlcompilation/intlcompilation.html.
CITI training completed at another institution is accepted as long as the other institution required the same modules (or more) in the CITI human subjects training as BGSU's. A training completion certification must be provided in IRBNet for Board viewing.